Advertisement

Introduction to School Psychopharmacology

  • John S. CarlsonEmail author
Chapter
Part of the Pediatric School Psychology book series (PSP)

Abstract

School Psychopharmacology: Translating Research into Practice uniquely contributes to the child psychopharmacology literature via its focus on service sector coordination, an emphasis on school-related medication treatment outcomes, a review of medication evaluations specific to the school context, and through its use of case study examples from the educational setting. This edited book brings together the latest in school psychopharmacology-related research and practice from experts across the fields of school psychology, clinical psychology, and child psychiatry. This introductory chapter reviews the importance of school psychopharmacology within the mental health treatment of children and adolescents and a preview of each chapter is presented.

Keywords

School psychopharmacology Psychotropic medication School-aged Integrated care Evidence-based interventions Side effects 

References

  1. American Academy of Pediatrics. (2011). ADHD: Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics, 128, 1007–1022.CrossRefGoogle Scholar
  2. American Psychological Association. (1995). Final report of the BEA working group to develop a Level 1 curriculum for psychopharmacology education and training. Washington, DC: Author.Google Scholar
  3. Anderson, L. E., Chen, M. L., Perrin, J. M., & Van Cleave, J. (2015). Outpatient visits and medication prescribing for US children with mental health conditions. Pediatrics, 136, e1178–e1185.CrossRefGoogle Scholar
  4. Bruns, E. J., Kerns, S. E. U., Pullmann, M. D., Hensley, S. W., Lutterman, T., & Hoagwood, K. E. (2016). Research, data, and evidence-based treatment use in state behavioral health systems, 2001–2012. Psychiatric Services, 67, 496–503.CrossRefGoogle Scholar
  5. Carlson, J. S. (2001). Empirical support for training in school psychopharmacology. Trainers’ Forum: Periodical of the Trainers of School Psychologists, 20, 6–11.Google Scholar
  6. Carlson, J. S., & Crossing, A. E. (2019). Arguments for and against the use of psychotropic medication within school-aged populations. In M. Burns (Ed.), Introduction to school psychology: Controversies and current practices. Oxford: Oxford University Press.Google Scholar
  7. Carlson, J. S., & Shahidullah, J. D. (2014). Best practices in assessing the effects of psychotropic medications on student performance. In P. L. Harrison & A. Thomas (Eds.), Best practices in school psychology: Systems-level services (pp. 361–374). Bethesda, MD: National Association of School Psychologists.Google Scholar
  8. Carlson, J. S., Thaler, C. L., & Hirsch, A. J. (2005). Psychotropic medication consultation in schools: An ethical and legal dilemma for school psychologists. Journal of Applied School Psychology, 22, 29–41.CrossRefGoogle Scholar
  9. Carlson, J. S., Brinkman, T., & Majewicz-Hefley, A. (2006). Promoting an understanding of medication treatment outcomes for school-aged children diagnosed with autism. The California School Psychologist, 11, 33–42.Google Scholar
  10. Carlson, J. S., Demaray, M. K., & Hunter-Oehmke, S. (2006). A survey of school psychologists’ knowledge and training in child psychopharmacology. Psychology in the Schools, 43, 623–633.Google Scholar
  11. Carlson, J. S., Kruer, J. L., Ogg, J. A., Mathiason, J. B., & Magen, J. (2007). Methylphenidate, atomoxetine, and caffeine: A primer for school psychologists. Journal of Applied School Psychology, 24, 127–146.CrossRefGoogle Scholar
  12. DuPaul, G., & Carlson, J. S. (2005). Child psychopharmacology: How school psychologists can contribute to effective outcomes. School Psychology Quarterly, 20, 206–221.CrossRefGoogle Scholar
  13. Ghandour, R. M., Sherman, L. J., Vladutiu, C. J., Ali, M. M., Lynch, S. E., Bitsko, R. H., & Blumberg, S. J. (2019). Prevalence and treatment of depression, anxiety, and conduct problems in US children. The Journal of Pediatrics, e3, 256–267. https://doi.org/10.1016/j.jpeds.2018.09.021.CrossRefGoogle Scholar
  14. Hicks, T. B., Shahidullah, J. D., Carlson, J. S., & Palejwala, M. (2014). Nationally Certified School Psychologists’ use and reported barriers to using evidence-based interventions in schools: The influence of graduate program training and education. School Psychology Quarterly, 29, 469–487. https://doi.org/10.1037/spq0000059.CrossRefPubMedGoogle Scholar
  15. Kubiszyn, T., Carlson, J. S., & DeHay, T. (2005). Pediatric psychopharmacology: An update on internalizing disorders. School Psychology Quarterly, 20, 135–154.CrossRefGoogle Scholar
  16. Lloyd, B. P., Torelli, J. N., & Symons, F. J. (2016). Issues in integrating psychotropic and intensive behavioral interventions for students with emotional and behavioral challenges. Journal of Emotional and Behavioral Disorders, 24, 148–158.CrossRefGoogle Scholar
  17. National Center for Education Statistics. (2018). Children and youth with disabilities. Retrieved November 29, 2018, from https://nces.ed.gov/programs/coe/indicator_cgg.asp.
  18. Olfson, M., & Marcus, S. C. (2010). National trends in outpatient psychotherapy. American Journal of Psychiatry, 167, 1456–1463.CrossRefGoogle Scholar
  19. Olfson, M., Druss, B. G., & Marcus, S. C. (2015). Trends in mental health care among children and adolescents. The New England Journal of Medicine, 372, 2029–2038.CrossRefGoogle Scholar
  20. Power, T. J., Eiraldi, R. B., Clarke, A. T., & Mazzuca, L. B. (2005). Improving mental health service utilization for children and adolescents. School Psychology Quarterly, 2005, 187–205.CrossRefGoogle Scholar
  21. Shahidullah, J. D., & Carlson, J. S. (2014). Survey of Nationally Certified School Psychologists’ roles and training in psychopharmacology. Psychology in the Schools, 51, 705–721.  https://doi.org/10.1002/pits.21776.CrossRefGoogle Scholar
  22. Simon, A. E., Pastor, P. N., Reuben, C. A., Huang, L. N., & Goldstrom, I. D. (2015). Use of mental health services by children ages six to 11 with emotional and behavioral difficulties. Psychiatric Services, 66, 930–937.  https://doi.org/10.1089/cap.2017.0077.CrossRefPubMedGoogle Scholar
  23. Sultan, R. S., Correll, C. U., Schoenbaum, M., King, M., Walkup, J. T., & Olfson, M. (2018). National patterns of commonly prescribed psychotropic medications to young people. Journal of Child and Adolescent Psychopharmacology, 28, 158–165.Google Scholar
  24. Torio, C. M., Encinosa, W., Berdahl, T., McCormick, M. C., & Simpson, L. A. (2015). Annual report on health care for children and youth in the United States: National estimates of cost, utilization and expenditures for children with mental health conditions. Academic Pediatrics, 15, 19–35.CrossRefGoogle Scholar
  25. Walter, A. W., Yuan, Y., & Cabral, H. J. (2017). Mental health services utilization and expenditures among children enrolled in employer-sponsored health plans. Pediatrics, 139, S127–S135.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Michigan State UniversityEast LansingUSA

Personalised recommendations